Transformation Is No Longer a Strategy Slide. It Is Capital Allocation.

What the world’s biggest consumer companies are quietly doing that most organizations are still only putting in PowerPoints.

Real transformation has a specific signature. It's ugly. It's controversial inside the organization. It cannibalizes things people love. And above all, it shows up in capital

allocation , not in keynotes.

The companies getting this right aren't announcing it. They're doing it through divestitures, portfolio redesign, and the quiet redeployment of capital toward businesses

that didn't exist in their core ten years ago.

The engine has stalled

For four decades, the FMCG playbook was simple: optimize the core, push margins through pricing and procurement, extend distribution, repeat. It worked because the underlying engine , stable demographics, genuine brand loyalty, predictable category

expansion , ran on autopilot.

That engine is no longer running.

Category growth in most developed markets is structurally slower. Private label penetration in Europe has crossed 35% in several key markets (NielsenIQ). The brand premium that once justified a 30% price gap now has to earn that premium every single quarter.

The optimization era didn't just slow down. It trained an entire generation of consumer. Goods leaders to mistake efficiency for strategy. Efficiency isn't strategy. It's table stakes.

Philip Morris: the most radical bet in consumer goods history

PMI is, by any traditional measure, a tobacco company. One of the most profitable businesses ever built. And PMI is deliberately, systematically engineering its own decline.

In its 2023 annual report, smoke-free products , led by IQOS and ZYN , represented approximately 39% of total net revenues, up from near zero a decade ago. Their stated ambition is to cross 50% in the medium term. That would mean the majority of revenues at one of the world's most iconic tobacco companies coming from products that barely existed 15 years ago.

This isn't a skunkworks project. PMI has spent billions building manufacturing, regulatory, and commercial infrastructure for smoke-free. They're funding the erosion of their own combustible business before regulators and generational shifts do it for them.

The lesson isn't about tobacco. It's about timing. PMI started the transition when the core was still generating extraordinary cash. The old machine paid for the new one. Most companies attempt transformation when the old model is already broken , by then, the capital is gone and urgency destroys strategic patience.

PepsiCo: redefining the occasion

U.S. carbonated soft drink consumption has dropped more than 25% from its late-1990s peak (Beverage Marketing Corporation). That's not a trend , it's a category in secular contraction.

And yet PepsiCo isn't in crisis. Because they made the right call about what business they're actually in.

PepsiCo isn't in the soda business. They're in the beverage occasion business. The acquisition of Poppi , the prebiotic soda brand with genuine cultural traction among younger consumers , signals they're entering emerging categories while they're still forming. The Celsius partnership extends their reach into energy. And Frito-Lay remains the margin engine that funds the riskier bets. What PepsiCo is NOT doing is equally instructive: they're not launching seventeen new cola flavors or defending carbonates with aggressive promotional spend. They're letting the old portfolio mature gracefully while building aggressively in adjacent occasion spaces.

Nestlé & Danone: when food companies behave like healthcare companies.

Nestlé Health Science , its medical nutrition, supplements, and health-focused division , is no longer a bolt-on. According to the 2023 annual report, the health science segment has been growing meaningfully faster than many traditional packaged food categories.

Gut health, active aging, metabolic support, clinical nutrition: these are now P&L contributors with dedicated sales infrastructure.

Danone tells the same story , consistently highlighting specialized and medical nutrition platforms as core growth vectors across its 2023 and 2024 earnings as certain dairy segments face volume stagnation in Western Europe and North America. When food companies file regulatory dossiers alongside product launches and hire scientific advisory boards, they're not doing marketing. They're executing a portfolio migration.

AB InBev & Diageo: the volume heresy

Per capita beer consumption in the U.S. has been declining. Morgan Stanley research noted Gen Z consumers drink less alcohol on average than any prior generation.

Traditional volume metrics are under structural pressure.AB InBev's response: systematically invest in premium and super-premium, Stella, Corona, Modelo, while letting economy-tier brands decline in relative priority.

Management has consistently highlighted premium mix shift as the key driver of revenue per hectoliter growth in earnings calls over the past two years. More revenue from fewer

liters sold.

Diageo went sharper: fewer brand launches, higher investment per core brand, explicit margin discipline. The luxury spirits segment , Johnnie Walker Blue, Don Julio 1942, Casamigos , commands 40–60% gross margins. One consumer buying a $70 super- premium tequila can generate more value than three consumers buying standard-tier

product. The old model was built on volume. The new model is built on value per consumer engagement.

The pattern hiding in plain sight

Across PMI, PepsiCo, Nestlé, Danone, AB InBev, and Diageo , and extending through Unilever's portfolio rationalization, Kraft Heinz's brutal simplification, P&G's brand reduction from 170+ to fewer than 65, and Coca-Cola's SKU rationalization they chose not to fully reverse , a coherent pattern emerges.

Capital is finite. Complexity is expensive. The future doesn't look like the past.

SKU rationalization isn't operations. It's strategic clarity made tangible. Every SKU that survives is a bet on where demand will be, not where it was. Every SKU that gets cut is a freed resource.

The CFO has become the unlikely protagonist of consumer goods transformation , not because finance people are better strategists, but because transformation that doesn't show up in capital allocation isn't transformation. It's aspiration. And aspiration doesn't compound.

The question nobody wants to answer out loud

The companies winning this decade share one uncomfortable characteristic: they're willing to shrink something today to build something bigger tomorrow.

That requires a specific kind of institutional courage that is remarkably rare. It means telling your best people that the business they built now needs to harvest, not invest. It means defending a portfolio decision to analysts watching your volume metrics decline in real time while the new bet is still pre-profitable.

Most organizations can't do this , not because the strategy is wrong, but because incentive structures, cultural identity, and planning cycles are all calibrated to defend existing positions rather than fund future ones.Most C-suites are asking: "How do we grow the core?"

The better question , the harder one , is: What are we willing to let shrink so the next business can scale?

Transformation isn't about adding capability. It's about choosing what not to fund. It's not about launching more things. It's about having the structural discipline to resource fewer bets more meaningfully.

Delaying that decision doesn't reduce risk. It compounds it , one quarter at a time, while

the market keeps moving.

The question isn't whether your industry will transform. It already is, the question is whether your capital allocation reflects that reality yet.

Where do you push back? Drop your perspective in the comments.

Sources

    1.    Philip Morris International Annual Report 2023 & Investor Presentations (Smoke-free revenue share data)

    2.    PMI Q4 2023 Earnings Call Transcript

    3.    Beverage Marketing Corporation – U.S. Carbonated Soft Drink Consumption Trends

    4.    PepsiCo Annual Report 2023 & Earnings Calls (Portfolio diversification and functional beverage strategy)

    5.    Nestlé Annual Report 2023 (Health Science segment performance)

    6.    Danone Earnings Releases 2023–2024 (Specialized nutrition growth commentary)

    7.    AB InBev Investor Presentations & Earnings Transcripts 2023

    8.    Diageo FY2023 Results & Strategy Commentary

    9.    Euromonitor International – Global Alcoholic Drinks Market Trends

    10.    McKinsey & Company – “The Future of Growth in Consumer Packaged Goods”

    11.    NielsenIQ Reports on Premiumization and Category Value Growth

    12.    Company filings and investor materials from Unilever, Kraft Heinz, Mondelez, P&G, Coca-Cola, L’Oréal, Estée Lauder, Colgate-Palmolive, Kimberly-Clark, Kenvue, Reckitt, Heineken, General Mills, Conagra, Clorox, Keurig Dr Pepper.

Growth

15min

Book Now